{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:57:19Z","timestamp":1761487039122},"reference-count":9,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":5942,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1093\/annonc\/mdg419","type":"journal-article","created":{"date-parts":[[2003,9,19]],"date-time":"2003-09-19T17:43:53Z","timestamp":1063993433000},"page":"1588-1589","source":"Crossref","is-referenced-by-count":9,"title":["Onycholysis secondary to multiple paclitaxel 1-hour infusions: possible role for its vehicle (Cremophor EL)"],"prefix":"10.1016","volume":"14","author":[{"given":"U.","family":"De Giorgi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Monti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.L.","family":"Frassineti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Marangolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdg419_bb0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/annonc\/mdg050","article-title":"Taxane-induced nail changes: incidence, clinical presentation and outcome","volume":"14","author":"Minisini","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdg419_bb0015","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2367::AID-CNCR22>3.0.CO;2-#","article-title":"Onycholysis as a complication of systemic chemotherapy. Report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature","volume":"88","author":"Hussain","year":"2000","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdg419_bb0020","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1023\/A:1008434626876","article-title":"Dose-intensified weekly paclitaxel induces multiple nail disorders","volume":"9","author":"L\u00fcftner","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdg419_bb0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1345\/aph.18307","article-title":"Onycholysis associated with weekly administration of paclitaxel","volume":"33","author":"Flory","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1093\/annonc\/mdg419_bb0030","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1200\/JCO.2002.99.147","article-title":"Nail toxicity related to weekly taxanes: an important issue requiring a change in common toxicity criteria grading?","volume":"20","author":"Spazzapan","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg419_bb0035","unstructured":"Cancer Therapy Evaluation Program. Common toxicity criteria manual: common toxicity criteria, version 2.0. Bethesda, MD: National Cancer Institute 1999 [on-line] http:\/\/ctep.cancer.gov\/forms\/CTCv20_4-30-992.pdf (date last accessed, 10 April 2003)."},{"key":"10.1093\/annonc\/mdg419_bb0040","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1200\/JCO.20.2.574","article-title":"Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions","volume":"20","author":"Gelderblom","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg419_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1010618632738","article-title":"Role of formulation vehicles in taxane pharmacology","volume":"19","author":"van Zuylen","year":"2001","journal-title":"Invest New Drugs"},{"key":"10.1093\/annonc\/mdg419_bb0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/annonc\/mdg078","article-title":"Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer","volume":"14","author":"Kruijtzer","year":"2003","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419641931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419641931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/14\/10\/1588\/420205\/mdg419.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T02:16:37Z","timestamp":1582251397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419641931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0923753419641931"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdg419","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}